the aid library

LIST OPTIONS

Filter

5334

Situation Analysis Antibiotic Use and Resistance in India

Public Health Foundation India (2011) C2

The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly ... more

Download (581)

View PDF (885)

Capacity Building Plan: Paraguay

OECD (2015) C1

External Link

The path that ends AIDS: UNAIDS Global AIDS Update 2023
recommended

UN Children's Fund UNICEF (2023) CC

This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not... more

Download (487)

View PDF (707)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (574)

View PDF (1021)

Philippines: 2014 Global AIDS Response Progress Reporting

UNAIDS (2014) C1

Download (734)

View PDF (1764)

WHO guidance for contingency planning
recommended

World Health Organization (WHO) (2018) C_WHO

In this contingency planning guidance, a set of actions to prepare for emergencies from all hazards and to help minimize their impact, is proposed. These actions include the development, implementation, simulation, monitoring and regular update of risks-based contingency plans.

Download (963)

View PDF (1314)

Prevention of mother-to-child transmission of HIV. Pocket Guide
recommended

Ministry of Health and Social Welfare, Tanzania (2013) C1

Option B+

Download (426)

View PDF (400)

Managing Yellow fever epidemics

World Health Organization WHO (2019) C_WHO

Download (679)

View PDF (1201)

Safe Handling, Treatment, Transport and Disposal of Ebola-Contaminated Waste

OSHA Occupational Safety and Health Administration (2014)

Download (139)

View PDF (119)

Plan of Action for Malaria Elimination 2021-2025

Pan American Health Organization PAHO (2022) C_WHO

The Plan subscribes to the goals and pillars of the WHO Global Technical Strategy against Malaria 2016-2030 (GTS), while presenting key elements to address the specific challenges of the Region.

Download (283)

View PDF (283)

Resource materials for in- country development and implementation of national action plans to address antimicrobial resistance

World Health Organization WHO (2021) C_WHO

Download (247)

View PDF (280)

COVID-19: Guidelines on Dead Body Management

Government of India; Ministry of Health & Family Welfare; Directorate General of Health Services (EMR Division) (2020) C2

This guideline is based on the current epidemiological knowledge about the COVID-19. India is currently having travel related cases and few cases of local transmission. At this stage, all suspect/ confirmed cases will be isolated in a health care facility. Hence the document is limited in scope to h... more

Download (505)

View PDF (1479)

Haiti: Cholera figures (18 November 2016)

UN Office for the Coordination of Humanitarian Affairs (2016) C1

This document summarizes Haiti's cholera situation as of November 16, 2016. Between January and October 2016, Haiti reported 35,203 new suspected cholera cases (32% increase from 2015) and 369 deaths (56% increase). After Hurricane Matthew, cases rose dramatically, with 52% of new cases concentrated... more

Download (1221)

View PDF (2376)

Clinical management of patients in the Ebola Treatment Centres and other care centres in Sierra Leone

Ministry of Health and Sanitation Sierra Leone; World Health Organization (2015)

Interim emergency guidelines

Download (841)

View PDF (754)

Joint External Evaluation of Sierra Leone: Mission Report November 2016

World Health Organization (WHO) (2016) C_WHO

Download (237)

View PDF (388)

National Comprehensive Covid19 Management Handbook First Edition 2020

Ministry of Health, Federal Democratic Republic of Ethiopia Ministry of Health, Federal Democratic Republic of Ethiopia (2020) C1

Cognizant of the need for standardization of the response for COVID-19, the Federal Ministry of Health prepared this national guideline in an effort to contain the epidemic before it overwhelms the health care facilities. This national guideline is expected to guide policy makers and h... more